Homology Medicines

General Information


We are a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Our proprietary platform is designed to utilize our human hematopoietic stem cell derived adeno-associated virus vectors, or AAVHSCs, to precisely and efficiently deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a broad range of genetic disorders.


Employees: 67
Founded: 2015
Contact Information
Address 45 Wiggins Avenue, Bedford, MA 01730, US
Phone Number (781) 301-7277
Web Address http://www.homologymedicines.com
View Prospectus: Homology Medicines
Financial Information
Market Cap $541.2mil
Revenues $0 mil (last 12 months)
Net Income $-29.99 mil (last 12 months)
IPO Profile
Symbol FIXX
Exchange NASDAQ
Shares (millions): 9.0
Price range $16.00 - $16.00
Est. $ Volume $144.0 mil
Manager / Joint Managers BofA Merrill Lynch/ Cowen/ Evercore ISI
CO-Managers BTIG
Expected To Trade: 3/28/2018
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change